Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- PMID: 30855755
- DOI: 10.1056/NEJMc1900150
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Comment in
-
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply.N Engl J Med. 2019 Mar 7;380(10):987-988. doi: 10.1056/NEJMc1900150. N Engl J Med. 2019. PMID: 30855757 No abstract available.
Comment on
-
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.N Engl J Med. 2018 Nov 29;379(22):2108-2121. doi: 10.1056/NEJMoa1809615. Epub 2018 Oct 20. N Engl J Med. 2018. PMID: 30345906 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources